Marion Chatfield is a manager in Statistical Sciences at GlaxoSmithKline (Hertfordshire).
Risk-Based Intermediate Precision Studies for Analytical Procedure Validation
September 15th 2019Validation of analytical procedures require assessment of the impact of variations within laboratories; however, guidance to study intermediate precision has been lacking. Science and risk-based principles should be used in the design of intermediate precision studies.
Evaluating Progress in Analytical Quality by Design
The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.